The Group refers to initiatives for creating
unique innovation in the life insurance
business as "InsTech," representing a
combination of the insurance business
and technology, and promotes
group-wide initiatives of
strategic importance.
Analysis and Utilization of Medical Big Data
The Group has reviewed underwriting standards based on analysis of medical big data. As a result, it now underwrites approximately 12,000 additional policies a year, which is approximately 1% of Dai-ichi Life's new policies). In addition, the Group has developed new products and services based on the results of analysis of medical big data, such as Kenko Nenrei®* (Health Age) and medical examination discounts.
Going forward, the Dai-ichi Life Group aims to contribute to improving quality of life and promoting extension of a healthy life span using big data analysis.
Offer new products and services while insurance coverage is offered to more people through the analysis of medical big data from internal and external resources
More User Friendly and Higher Productivity Through Innovation
The Group is working to increase convenience for customers by digitalization of various administrative processes and to raise productivity by introducing RPA* and AI technologies. Through these initiatives and other measures such as work-style reform, the Group will shift human resources equivalent to 2,100 personnel into growth sectors over the next five years.
* RPA: Robotic process automation
Significant improvements in convenience and productivity through digitalization of user interface, automation of back office operation
Driving Innovation
The Group is picking up the pace in innovation to create new markets and hone its competitive edge instead of simply enhancing the current business model and engaging in price competition. In April 2018, the Group established the Dai-ichi Life Innovation Lab in Shibuya, Tokyo, and Silicon Valley, U.S., as part of its efforts to create markets and create new demand by providing new added value in the healthcare domain and domains that target the senior age group by repeatedly conducting small-scale proof-of-concept studies in a flexible manner.
Pursue creation of new social value focusing on three main areas: Expansion of insurance business domain, tapping into the health care domain closely affiliated with life insurance, and offer value to senior age group
Strengthen global collaboration and actively adopt cutting-edge technology from overseas
by establishing labs in Tokyo and Silicon Valley
Dai-ichi Life Innovation Lab Tokyo
Dai-ichi Life Innovation Lab Silicon Valley